Precision Medicine Research Studies

  • (101-18) Registry of patients in kindreds with germ-line TP53 mutations (Li-Fraumeni) (Research study, appropriate for patients with a germline mutation in TP53.)
  • (135-17) Caris Molecular Intelligence® and Caris Centers of Excellence for Precision Medicine NetworkTM Outcomes Associated Repository (Phase 4 research study, appropriate for patients with all cancers.)
  • (136-17) Caris Molecular Intelligence® and Caris Centers of Excellence for Precision Medicine NetworkTM Retrospective Outcomes-Associated Database (Phase 4 research study, appropriate for patients with all cancers.)
  • (179-17) Pilot program to assess the potential role of pharmacogenomics to improve drug safety in patients with advanced cancer. (Research study, appropriate for patients with thyroid cancer.)
  • (204-17) Advance Treatment of Rare Tumors (Phase 4 research study, appropriate for patients with rare tumors.)

With questions, please contact Hoag's Clinical Trials department at 949-764-5543.